Wearable device zaps pancreatic tumors in new trial
NCT ID NCT07284277
Summary
This study is testing whether a wearable device that delivers low-intensity electric fields (called TTFields) is safe and helpful when used alongside standard chemotherapy for advanced pancreatic cancer that has spread. It will involve about 30 adults to see if the combination can better control the cancer and improve survival. The main goal is to check for side effects and see if patients can comfortably use the device along with their chemo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clínica Universidad de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
-
Fundación Jiménez-Díaz
NOT_YET_RECRUITINGMadrid, 28040, Spain
-
Hospital Universitario de Araba
NOT_YET_RECRUITINGVitoria-Gasteiz, Álava, 01009, Spain
-
Hospital Universitario de Cruces
NOT_YET_RECRUITINGBarakaldo, Vizcaya, 48903, Spain
-
Hospital de Galdakao
NOT_YET_RECRUITINGGaldakao, Vizcaya, 48960, Spain
Conditions
Explore the condition pages connected to this study.